Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale EVP, Chief Commercial Officer sold 8,542 shares at $62.15 ($530,885)
  2. 4 Open-market sale EVP Research & Development sold 12,033 shares at $62.15 ($747,851)
  3. 4 Open-market sale President & CEO sold 36,601 shares at $62.15 ($2,274,752)
  4. 4 Planned sale EVP, Chief Commercial Officer sold 1,930 shares at $62.07 ($119,795)
  5. 144 Insider Sale of Securities
  6. 4 Grant or award President & CEO acquired 75,258 shares (grant or award)
  7. 4 Grant or award EVP, Chief Commercial Officer acquired 33,966 shares (grant or award)
  8. 4 Grant or award Chief Legal & Admin Officer acquired 20,646 shares (grant or award)
  9. 4 Grant or award EVP, Chief Financial Officer acquired 20,646 shares (grant or award)
  10. 4 Grant or award EVP Research & Development acquired 27,306 shares (grant or award)
  11. 4 Planned sale EVP, Chief Commercial Officer sold 1,709 shares at $61.03 ($104,300)
  12. 144 Insider Sale of Securities
  13. 4 Open-market sale EVP, Chief Commercial Officer sold 2,582 shares at $60.72 ($156,779)
  14. 4 Open-market sale EVP Research & Development sold 2,907 shares at $60.72 ($176,513)
  15. 4 Open-market sale President & CEO sold 7,931 shares at $60.72 ($481,570)
  16. 4 Planned sale EVP, Chief Commercial Officer sold 26,000 shares at an average $61.87 ($1,608,730)
  17. 144 Insider Sale of Securities
  18. 4 Planned sale Director sold 5,000 shares at $61.21 ($306,050)
  19. 4 Planned sale EVP, Chief Commercial Officer sold 886 shares at $61.62 ($54,595)
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 7 of 127 · 2,534 filings